Affiliation:
1. Mordovian State University named after N.P. Ogareva
2. Volgograd State Medical University of the Ministry of Health of Russia
3. Mordovian State University named after N.P. Ogarev
Abstract
Amyloidosis is a group of diseases characterized by the deposition of a protein having
a fibrillar structure in the organs and tissues of the body. The main difference between amyloid is a high ordering of the structure, which manifests itself in the ability to birefringence in combination with dichroism, i.e. a change in the red colour of amyloid deposits to apple green in polarized light. Today, the disease has stopped to be a rare one, but the similarity of clinical data with well-known diseases increases the timing of diagnosis, affects the prognosis and survival of patients. Rare forms of amyloidosis, the description of which is reflected in this article, deserve special attention.
Publisher
PANORAMA Publishing House
Reference14 articles.
1. Kuzmichev D.E., Skrebov R.V., Chirkov S.V., Viltsev I.M. Amyloidosis. // Healthcare of Ugra: experience and innovations. 2016. № 1. P. 59-65.
2. National clinical guidelines. "Diagnosis and treatment of AA - and AL amyloidosis". Scientific Society of Nephrologists of Russia. Association of Nephrologists of Russia. 2014. - 30 p.
3. Demko I.V., Pelinovskaya L.I., Soloviyova I.A. et al. Primary amyloidosis of the heart. // Clinical medicine. 2017. № 95 (11). P. 971-976.
4. Novikova R.A., Alekseychik S.E., Goncharik T.A. and others. Multiple myeloma. Amyloidosis of the heart. Clinical case. // Military medicine. 2018. № 3. P. 137-142.
5. Draganova A.S., Soboleva A.V., Ertman A.E. Hereditary systemic transthyretin amyloidosis: a clinical case and opinion on the problem. // Russian Journal of Cardiology. 2019. № 24 (6). P. 136-142.